Lanzon, Renielyn .
HRN: 24-54-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2024
MUPIROCIN 2%, 15G (TUBE)
02/18/2024
02/22/2024
APPLY ON SKIN
Thinly
Q8h
IV Site Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes